Treasure Sea Limited increases its stake in CMS (00867) by 500,000 shares, with an estimated price of approximately HK$7.55 per share.
On September 19th, Treasure Sea Limited increased its holdings of Kangzhe Pharmaceutical (00867) by 500,000 shares, with a price of 7.546 Hong Kong dollars per share, totaling 3.773 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on September 19th, Treasure Sea Limited increased its holdings of CMS (00867) by 500,000 shares at a price of 7.546 Hong Kong dollars per share, with a total amount of 3.773 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 1.166 billion shares, and the latest shareholding ratio is 47.80%.
This transaction involves another related party: Lin Gang.
Related Articles
Guotai Haitong: Maintains a "buy" rating on CSSC SHIPPING (03877) and raises the target price to HK$2.72
Morgan Stanley: Optimistic about the prospects of strategic transformation + positioning better than market expectations, giving Appian (APPN.US) a "hold" rating.
Roche (RHHBY.US) will acquire 89bio (ETNB.US) for up to $3.5 billion to increase its presence in the weight loss drug market.
Guotai Haitong: Maintains a "buy" rating on CSSC SHIPPING (03877) and raises the target price to HK$2.72
Morgan Stanley: Optimistic about the prospects of strategic transformation + positioning better than market expectations, giving Appian (APPN.US) a "hold" rating.
Roche (RHHBY.US) will acquire 89bio (ETNB.US) for up to $3.5 billion to increase its presence in the weight loss drug market.
